Nampak reported financials for the six months ended March 31, 2025, achieving a 22% increase in trading profit and a 7% rise in operating profit. Revenue growth, margin expansion, and cost efficiencies drove top-line growth, while a pension fund surplus and a Covid-19 insurance settlement boosted headline earnings, though less significantly than a prior-year medical aid gain. For continuing operations, headline earnings per share (HEPS) are expected to rise by 1 to 8% to between 5,450 and 5,850 cents.
Click here to read the SENS